New findings link commonly prescribed drugs to certain health risks—prompting experts to urge caution for older adults.

UNIVERSITY PARK, Pa. — Insomnia is a significant health and quality of life concern for older adults, with up to half of all adults over the age of 65 experiencing insomnia symptoms. In a new study, ...

HealthDay News — Reducing future use of sleep medications could help older adults live healthier lives with fewer limitations, according to a study published online Oct. 24 in The Lancet Regional ...

A new study from Penn State University found that older adults who experience symptoms of insomnia and/or use sleep medications face a substantially higher risk of developing disabilities that affect ...

Millions of older Americans suffering from insomnia regularly use prescription sleep medications, despite the risk of serious ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost an ...

Adults with chronic insomnia who used melatonin for a year or more were more likely to be diagnosed with and hospitalized for ...

Chronic insomnia needs evidence-based care, not pills or products. Consistent habits, CBT-I, and understanding sleep—not ...

Please provide your email address to receive an email when new articles are posted on . A total of 69.5% of patients with insomnia aged 65 years and older were misusing medication. Extended duration ...

When you want to sleep, you go to bed, lie down, and close your eyes. Simple, right? Well, not quite. For many, this is a luxury they cannot afford. Global data shows that one in every six adults ...

The Food and Drug Administration has approved a GLP-1 agonist for treating sleep apnea. Here’s how it works and what you can expect.

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...